FR2953521B1 - Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
FR2953521B1
FR2953521B1 FR0905953A FR0905953A FR2953521B1 FR 2953521 B1 FR2953521 B1 FR 2953521B1 FR 0905953 A FR0905953 A FR 0905953A FR 0905953 A FR0905953 A FR 0905953A FR 2953521 B1 FR2953521 B1 FR 2953521B1
Authority
FR
France
Prior art keywords
hex
derivatives
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0905953A
Other languages
English (en)
French (fr)
Other versions
FR2953521A1 (fr
Inventor
Patrick Casara
Anne Marie Chollet
Alain Dhainaut
Jean Michel Henlin
Pierre Lestage
Fany Panayi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42711699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2953521(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Priority to FR0905953A priority Critical patent/FR2953521B1/fr
Priority to UY0001033072A priority patent/UY33072A/es
Priority to TW099142190A priority patent/TW201200499A/zh
Priority to ARP100104484A priority patent/AR079265A1/es
Priority to SA110320011A priority patent/SA110320011B1/ar
Priority to EP10799080A priority patent/EP2509947A1/fr
Priority to MX2012006578A priority patent/MX2012006578A/es
Priority to CA2782469A priority patent/CA2782469C/fr
Priority to US13/514,796 priority patent/US20120283245A1/en
Priority to JP2012542591A priority patent/JP2013513589A/ja
Priority to AP2012006352A priority patent/AP2012006352A0/xx
Priority to UAA201208178A priority patent/UA102950C2/ru
Priority to AU2010329762A priority patent/AU2010329762B2/en
Priority to KR1020127017843A priority patent/KR20120102763A/ko
Priority to SG2012038931A priority patent/SG181082A1/en
Priority to PH1/2012/501053A priority patent/PH12012501053A1/en
Priority to PE2012000722A priority patent/PE20121475A1/es
Priority to EA201200849A priority patent/EA201200849A1/ru
Priority to BR112012013666A priority patent/BR112012013666A2/pt
Priority to MA34932A priority patent/MA33882B1/fr
Priority to PCT/FR2010/000823 priority patent/WO2011070253A1/fr
Priority to IN4966DEN2012 priority patent/IN2012DN04966A/en
Priority to CN2010800559947A priority patent/CN102652127A/zh
Priority to GEAP201012774A priority patent/GEP20156227B/en
Publication of FR2953521A1 publication Critical patent/FR2953521A1/fr
Application granted granted Critical
Publication of FR2953521B1 publication Critical patent/FR2953521B1/fr
Priority to TNP2012000267A priority patent/TN2012000267A1/fr
Priority to CR20120286A priority patent/CR20120286A/es
Priority to ZA2012/03943A priority patent/ZA201203943B/en
Priority to ECSP12011950 priority patent/ECSP12011950A/es
Priority to CO12095636A priority patent/CO6541535A2/es
Priority to CL2012001479A priority patent/CL2012001479A1/es
Priority to CU20120091A priority patent/CU20120091A7/es
Priority to NI201200099A priority patent/NI201200099A/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0905953A 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Expired - Fee Related FR2953521B1 (fr)

Priority Applications (32)

Application Number Priority Date Filing Date Title
FR0905953A FR2953521B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY0001033072A UY33072A (es) 2009-12-09 2010-12-01 Nuevos derivados de azabiciclo[3.1.0.]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
TW099142190A TW201200499A (en) 2009-12-09 2010-12-03 New azabicyclo[3.1.0] hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
ARP100104484A AR079265A1 (es) 2009-12-09 2010-12-06 Derivados de azabiciclo(3.1.0)hex-2-ilo, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
SA110320011A SA110320011B1 (ar) 2009-12-09 2010-12-07 مركبات آزا باي سيكلو [3. 1. صفر] هكس-2-يل جديدة، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها
PE2012000722A PE20121475A1 (es) 2009-12-09 2010-12-08 Nuevos derivados de azabiciclo[3.1.0]hex-2-ilo, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
PCT/FR2010/000823 WO2011070253A1 (fr) 2009-12-09 2010-12-08 Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2782469A CA2782469C (fr) 2009-12-09 2010-12-08 Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US13/514,796 US20120283245A1 (en) 2009-12-09 2010-12-08 Azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
JP2012542591A JP2013513589A (ja) 2009-12-09 2010-12-08 アザビシクロ［３．１．０］ヘキサ−２−イル誘導体、その調製方法、及びそれを含有する医薬組成物
AP2012006352A AP2012006352A0 (en) 2009-12-09 2010-12-08 AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same.
UAA201208178A UA102950C2 (ru) 2009-12-09 2010-12-08 Азабицикло[3.1.0]гекс-2-иловые соединения, способ их получения и фармацевтическая композиция, которая их содержит
AU2010329762A AU2010329762B2 (en) 2009-12-09 2010-12-08 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
KR1020127017843A KR20120102763A (ko) 2009-12-09 2010-12-08 아자바이사이클로〔3.1.0〕헥스-2-일 유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
SG2012038931A SG181082A1 (en) 2009-12-09 2010-12-08 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
PH1/2012/501053A PH12012501053A1 (en) 2009-12-09 2010-12-08 New azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
EP10799080A EP2509947A1 (fr) 2009-12-09 2010-12-08 Derives azabicyclo [3.1.0]hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA201200849A EA201200849A1 (ru) 2009-12-09 2010-12-08 Новые азабицикло[3.1.0]гекс-2-ильные соединения, способ их получения и фармацевтические композиции, содержащие их
BR112012013666A BR112012013666A2 (pt) 2009-12-09 2010-12-08 compostos de azabiciclo[3.1.0]hex-2-ila, processo para sua preparação e composições farmacêuticas que os contêm
MA34932A MA33882B1 (fr) 2009-12-09 2010-12-08 Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2012006578A MX2012006578A (es) 2009-12-09 2010-12-08 Derivados de azabiciclo[3.1.0]hex-2-ilo, metodo para prepararlos, y composiciones farmaceuticas que los contienen.
IN4966DEN2012 IN2012DN04966A (enExample) 2009-12-09 2010-12-08
CN2010800559947A CN102652127A (zh) 2009-12-09 2010-12-08 氮杂双环[3.1.0]己-2-基衍生物、制备方法和包含它们的药物组合物
GEAP201012774A GEP20156227B (en) 2009-12-09 2010-12-08 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
TNP2012000267A TN2012000267A1 (fr) 2009-12-09 2012-05-28 Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CR20120286A CR20120286A (es) 2009-12-09 2012-05-29 Nuevos derivados de azabiciclo[3.1.0]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ZA2012/03943A ZA201203943B (en) 2009-12-09 2012-05-30 New azabicyclo[3.1.0]hex-2-yl compounds,a process for their preparation and pharmaceutical compositions containing them
ECSP12011950 ECSP12011950A (es) 2009-12-09 2012-06-05 Nuevos derivados de azabiciclo[3.1.0]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2012001479A CL2012001479A1 (es) 2009-12-09 2012-06-06 Compuestos derivados de azabiciclo[3.1.0]hex-2-ilo, inhibidores de acetilcolinesterasa; compuestos intermediarios; composicion farmaceutica; utiles en el tratamiento de trastornos del sueño, tal como narcolepsia, hipersomnias, somnolencias diurnas.
CO12095636A CO6541535A2 (es) 2009-12-09 2012-06-06 Nuevos derivados de azabiciclicos [3.1.0] hex-2- ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
NI201200099A NI201200099A (es) 2009-12-09 2012-06-07 Nuevos derivados de azabiciclo [ 3.1.0] hex - 2 - ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20120091A CU20120091A7 (es) 2009-12-09 2012-06-07 Nuevos derivados de azabiciclo[3.1.0]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0905953A FR2953521B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FR2953521A1 FR2953521A1 (fr) 2011-06-10
FR2953521B1 true FR2953521B1 (fr) 2011-11-18

Family

ID=42711699

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0905953A Expired - Fee Related FR2953521B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (32)

Country Link
US (1) US20120283245A1 (enExample)
EP (1) EP2509947A1 (enExample)
JP (1) JP2013513589A (enExample)
KR (1) KR20120102763A (enExample)
CN (1) CN102652127A (enExample)
AP (1) AP2012006352A0 (enExample)
AR (1) AR079265A1 (enExample)
AU (1) AU2010329762B2 (enExample)
BR (1) BR112012013666A2 (enExample)
CA (1) CA2782469C (enExample)
CL (1) CL2012001479A1 (enExample)
CO (1) CO6541535A2 (enExample)
CR (1) CR20120286A (enExample)
CU (1) CU20120091A7 (enExample)
EA (1) EA201200849A1 (enExample)
EC (1) ECSP12011950A (enExample)
FR (1) FR2953521B1 (enExample)
GE (1) GEP20156227B (enExample)
IN (1) IN2012DN04966A (enExample)
MA (1) MA33882B1 (enExample)
MX (1) MX2012006578A (enExample)
NI (1) NI201200099A (enExample)
PE (1) PE20121475A1 (enExample)
PH (1) PH12012501053A1 (enExample)
SA (1) SA110320011B1 (enExample)
SG (1) SG181082A1 (enExample)
TN (1) TN2012000267A1 (enExample)
TW (1) TW201200499A (enExample)
UA (1) UA102950C2 (enExample)
UY (1) UY33072A (enExample)
WO (1) WO2011070253A1 (enExample)
ZA (1) ZA201203943B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016529307A (ja) * 2013-09-09 2016-09-23 サノフイ アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
EP1960383B1 (en) * 2005-11-30 2010-04-28 F. Hoffmann-la Roche AG 5-substituted indole-2-carboxamide derivatives

Also Published As

Publication number Publication date
IN2012DN04966A (enExample) 2015-09-25
AU2010329762A1 (en) 2012-06-21
ZA201203943B (en) 2013-08-28
BR112012013666A2 (pt) 2016-04-19
MA33882B1 (fr) 2013-01-02
TW201200499A (en) 2012-01-01
CU20120091A7 (es) 2012-07-31
TN2012000267A1 (fr) 2013-12-12
AR079265A1 (es) 2012-01-04
US20120283245A1 (en) 2012-11-08
AP2012006352A0 (en) 2012-08-31
CN102652127A (zh) 2012-08-29
JP2013513589A (ja) 2013-04-22
UY33072A (es) 2011-05-31
CL2012001479A1 (es) 2013-02-08
PH12012501053A1 (en) 2013-02-04
WO2011070253A1 (fr) 2011-06-16
FR2953521A1 (fr) 2011-06-10
CO6541535A2 (es) 2012-10-16
EA201200849A1 (ru) 2013-01-30
SA110320011B1 (ar) 2013-10-01
NI201200099A (es) 2012-11-09
CR20120286A (es) 2012-08-20
CA2782469C (fr) 2014-04-08
KR20120102763A (ko) 2012-09-18
PE20121475A1 (es) 2012-10-20
MX2012006578A (es) 2012-06-25
GEP20156227B (en) 2015-01-26
ECSP12011950A (es) 2012-07-31
EP2509947A1 (fr) 2012-10-17
UA102950C2 (ru) 2013-08-27
CA2782469A1 (fr) 2011-06-16
SG181082A1 (en) 2012-07-30
AU2010329762B2 (en) 2013-10-03
WO2011070253A8 (fr) 2012-08-02

Similar Documents

Publication Publication Date Title
FR2943342B1 (fr) Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2986002B1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2920773B1 (fr) Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2929276B1 (fr) Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA29225B1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2934596B1 (fr) Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
FR2909379B1 (fr) Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866647B1 (fr) Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2912145B1 (fr) Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2924713B1 (fr) Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2903404B1 (fr) Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2916757B1 (fr) Nouveaux derives diazeniumdiolates,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2902428B1 (fr) Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885616B1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2948372B1 (fr) Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933983B1 (fr) Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
MA29223B1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953515B1 (fr) Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953521B1 (fr) Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918370B1 (fr) Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2896800B1 (fr) Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2964969B1 (fr) Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA29224B1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2947266B1 (fr) Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150831